| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |